Patents by Inventor Cathlin Flamme

Cathlin Flamme has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060142312
    Abstract: The present invention provides substituted 2-aminopyridines of formula I, wherein R1, A1, W, X, and Y are as defined in the specification, useful in treating cell proliferative disorders. The novel compounds of the present invention are potent inhibitors of cyclin-dependent kinases 4 (Cdk4).
    Type: Application
    Filed: December 23, 2004
    Publication date: June 29, 2006
    Inventors: Cathlin Flamme, Douglas Johnson, Dennis McNamara, Debra Sherry, Peter Toogood, Scott VanderWel
  • Publication number: 20050026970
    Abstract: The present invention relates to N-methyl-substituted benzamidazole derivatives of formula (I): as defined in the specification; pharmaceutical compositions and methods of use thereof.
    Type: Application
    Filed: July 22, 2004
    Publication date: February 3, 2005
    Inventors: Stephen Barrett, Cathlin Flamme, Michael Kaufman, Jared Milbank, Haile Tecle, Joseph Warmus
  • Publication number: 20050004186
    Abstract: This invention provides substituted Phenyl-(2-[1,3,4]thiadiazol-2-yl-phenyl)-amine and (2-[1,3,4]Oxadiazol-2-yl-phenyl)phenyl-amine compounds which act as inhibitors of MAPK/ERK Kinase (“MEK”) enzymes and pharmaceutical compositions and methods for their use in immunomodulation and in the treatment and alleviation of inflammation, and proliferative diseases such as cancer and restenosis.
    Type: Application
    Filed: December 1, 2003
    Publication date: January 6, 2005
    Inventors: Stephen Barrett, Cathlin Flamme, Michael Kaufman, Mark Plummer, Jessica Reed, Joseph Warmus, Lu-Yan Zhang